BUZZ-<a href="https://laohu8.com/S/VOR">Vor Biopharma</a> plunges after $100 mln stock offering launch
** Vor Biopharma's VOR.O shares down 29% post-market at $13.35 as co seeks equity raise
** Autoimmune disease-focused biotech commences $100 mln stock offering
** JP Morgan, Jefferies, Citigroup and TD Cowen are joint bookrunners
** Boston-based VOR has ~6.84 mln shares outstanding for roughly $130 mln market cap, per LSEG data
** VOR effected a 1-for-20 reverse stock split in Sept
** VOR shares on Mon ended up 0.5% at $18.80
** Stock has gained ~449% over the past six months, putting it up ~15% YTD
(Lance Tupper is a Reuters market analyst. The views expressed are his own)
((lance.tupper@tr.com 1-646-279-6380))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.